157 related articles for article (PubMed ID: 31867736)
1. Prognostic and therapeutic implications of NHERF1 expression and regulation in colorectal cancer.
Leiphrakpam PD; Lazenby AJ; Chowdhury S; Smith LM; Mathiesen M; Brattain MG; Wang J; Black JD; Are C
J Surg Oncol; 2020 Mar; 121(3):547-560. PubMed ID: 31867736
[TBL] [Abstract][Full Text] [Related]
2. Ezrin expression and cell survival regulation in colorectal cancer.
Leiphrakpam PD; Rajput A; Mathiesen M; Agarwal E; Lazenby AJ; Are C; Brattain MG; Chowdhury S
Cell Signal; 2014 May; 26(5):868-79. PubMed ID: 24462708
[TBL] [Abstract][Full Text] [Related]
3. β-catenin knockdown promotes NHERF1-mediated survival of colorectal cancer cells: implications for a double-targeted therapy.
Saponaro C; Sergio S; Coluccia A; De Luca M; La Regina G; Mologni L; Famiglini V; Naccarato V; Bonetti D; Gautier C; Gianni S; Vergara D; Salzet M; Fournier I; Bucci C; Silvestri R; Passerini CG; Maffia M; Coluccia AML
Oncogene; 2018 Jun; 37(24):3301-3316. PubMed ID: 29551770
[TBL] [Abstract][Full Text] [Related]
4. β-catenin interaction with NHERF1 and RASSF1A methylation in metastatic colorectal cancer patients.
Schirosi L; Mazzotta A; Opinto G; Pinto R; Graziano G; Tommasi S; Fucci L; Simone G; Mangia A
Oncotarget; 2016 Oct; 7(42):67841-67850. PubMed ID: 27765918
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of nuclear NHERF1 in advanced colorectal cancer: association with hypoxic microenvironment and tumor invasive phenotype.
Malfettone A; Silvestris N; Paradiso A; Mattioli E; Simone G; Mangia A
Exp Mol Pathol; 2012 Jun; 92(3):296-303. PubMed ID: 22440733
[TBL] [Abstract][Full Text] [Related]
6. Involvement of nuclear NHERF1 in colorectal cancer progression.
Mangia A; Saponaro C; Malfettone A; Bisceglie D; Bellizzi A; Asselti M; Popescu O; Reshkin SJ; Paradiso A; Simone G
Oncol Rep; 2012 Sep; 28(3):889-94. PubMed ID: 22766563
[TBL] [Abstract][Full Text] [Related]
7. NHERF1/EBP50 is a new marker in colorectal cancer.
Hayashi Y; Molina JR; Hamilton SR; Georgescu MM
Neoplasia; 2010 Dec; 12(12):1013-22. PubMed ID: 21170265
[TBL] [Abstract][Full Text] [Related]
8. NHERF1 regulates the progression of colorectal cancer through the interplay with VEGFR2 pathway.
Gu Y; Yu H; Hao C; Martin TA; Hargest R; He J; Cheng S; Jiang WG
Oncotarget; 2017 Jan; 8(5):7753-7765. PubMed ID: 27999191
[TBL] [Abstract][Full Text] [Related]
9. High density of tryptase-positive mast cells in human colorectal cancer: a poor prognostic factor related to protease-activated receptor 2 expression.
Malfettone A; Silvestris N; Saponaro C; Ranieri G; Russo A; Caruso S; Popescu O; Simone G; Paradiso A; Mangia A
J Cell Mol Med; 2013 Aug; 17(8):1025-37. PubMed ID: 23991686
[TBL] [Abstract][Full Text] [Related]
10. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
Wang D; Fu L; Sun H; Guo L; DuBois RN
Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
[TBL] [Abstract][Full Text] [Related]
11. Expression of NHERF1 in colonic tumors induced by 1,2-dimethylhydrazine in rats is independent of plasma ovarian steroids.
Troncoso M; Cuello Carrión FD; Guiñazu E; Fanelli MA; Montt-Guevara M; Cabrini RL; Carón RW; Kreimann EL
Horm Cancer; 2011 Aug; 2(4):214-23. PubMed ID: 21761111
[TBL] [Abstract][Full Text] [Related]
12. Cullin1 is a novel prognostic marker and regulates the cell proliferation and metastasis in colorectal cancer.
Wang W; Chen Y; Deng J; Zhou J; Gu X; Tang Y; Zhang G; Tan Y; Ge Z; Huang Y; Wang S; Zhou J; Zhou Y; Zhou S
J Cancer Res Clin Oncol; 2015 Sep; 141(9):1603-12. PubMed ID: 25652886
[TBL] [Abstract][Full Text] [Related]
13. IGF1-mediated HOXA13 overexpression promotes colorectal cancer metastasis through upregulating ACLY and IGF1R.
Qiao C; Huang W; Chen J; Feng W; Zhang T; Wang Y; Liu D; Ji X; Xie M; Sun M; Fan D; Wu K; Xia L
Cell Death Dis; 2021 Jun; 12(6):564. PubMed ID: 34075028
[TBL] [Abstract][Full Text] [Related]
14. Stathmin expression in metastatic colorectal cancer.
Leiphrakpam PD; Lazenby AJ; Smith LM; Brattain MG; Are C
J Surg Oncol; 2021 May; 123(8):1764-1772. PubMed ID: 33765336
[TBL] [Abstract][Full Text] [Related]
15. Nuclear NHERF1 expression as a prognostic marker in breast cancer.
Paradiso A; Scarpi E; Malfettone A; Addati T; Giotta F; Simone G; Amadori D; Mangia A
Cell Death Dis; 2013 Nov; 4(11):e904. PubMed ID: 24201803
[TBL] [Abstract][Full Text] [Related]
16. SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate.
Wong CC; Qian Y; Li X; Xu J; Kang W; Tong JH; To KF; Jin Y; Li W; Chen H; Go MY; Wu JL; Cheng KW; Ng SS; Sung JJ; Cai Z; Yu J
Gastroenterology; 2016 Nov; 151(5):945-960.e6. PubMed ID: 27451147
[TBL] [Abstract][Full Text] [Related]
17. SPON2, a newly identified target gene of MACC1, drives colorectal cancer metastasis in mice and is prognostic for colorectal cancer patient survival.
Schmid F; Wang Q; Huska MR; Andrade-Navarro MA; Lemm M; Fichtner I; Dahlmann M; Kobelt D; Walther W; Smith J; Schlag PM; Stein U
Oncogene; 2016 Nov; 35(46):5942-5952. PubMed ID: 26686083
[TBL] [Abstract][Full Text] [Related]
18. Repressing of NHERF1 inhibits liver cancer progression by promoting the production of ROS.
Sun J; Li P; Yang J
Biochem Biophys Res Commun; 2019 Jan; 509(1):8-15. PubMed ID: 30581004
[TBL] [Abstract][Full Text] [Related]
19. Nuclear expression of NHERF1/EBP50 in Clear Cell Renal Cell Carcinoma.
Lema BE; Patricio GM; Kreimann EL
Acta Histochem; 2021 Jul; 123(5):151717. PubMed ID: 33965858
[TBL] [Abstract][Full Text] [Related]
20. Loss of SMAD4 from colorectal cancer cells promotes CCL15 expression to recruit CCR1+ myeloid cells and facilitate liver metastasis.
Itatani Y; Kawada K; Fujishita T; Kakizaki F; Hirai H; Matsumoto T; Iwamoto M; Inamoto S; Hatano E; Hasegawa S; Maekawa T; Uemoto S; Sakai Y; Taketo MM
Gastroenterology; 2013 Nov; 145(5):1064-1075.e11. PubMed ID: 23891973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
